{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:44:19Z","timestamp":1777671859114,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.clinthera.2024.01.010","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T13:16:28Z","timestamp":1709212588000},"page":"354-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Attainment of Target in Therapeutic Range of International Normalized Ratio and Correlates Among Patients on Warfarin Therapy at Jimma Medical Center, Jimma, Ethiopia"],"prefix":"10.1016","volume":"46","author":[{"given":"Abdulkadir Urgessa","family":"Jada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gashahun Mekonnen","family":"Disassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belete Habte","family":"Melesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2769-1772","authenticated-orcid":false,"given":"Mohammed Mecha","family":"Abafogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyob Girma","family":"Abera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelil Hussein","family":"Jibicho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kedir Negesso","family":"Tukeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2024.01.010_bib0001","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.dld.2015.03.029","article-title":"Management of anticoagulation in patients with acute gastrointestinal bleeding","volume":"47","author":"Radaelli","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinthera.2024.01.010_bib0002","doi-asserted-by":"crossref","first-page":"e531S","DOI":"10.1378\/chest.11-2304","article-title":"Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"You","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2024.01.010_bib0003","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2024.01.010_bib0004","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2024.01.010_bib0005","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199211193272103","article-title":"Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis","volume":"327","author":"Brandjes","year":"1992","journal-title":"N Engl J Med"},{"issue":"8519","key":"10.1016\/j.clinthera.2024.01.010_bib0006","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(86)91431-5","article-title":"Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism","volume":"328","author":"Gallus","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2024.01.010_bib0007","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"13","author":"January","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.clinthera.2024.01.010_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005379","article-title":"Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review","volume":"4","author":"Mearns","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinthera.2024.01.010_bib0009","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/jcp.56.1.48","article-title":"A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation","volume":"56","author":"Fitzmaurice","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clinthera.2024.01.010_bib0010","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinthera.2024.01.010_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-017-2330-0","article-title":"Quality of anticoagulation management with warfarin among outpatients in a tertiary hospital in Addis Ababa, Ethiopia: a retrospective cross-sectional study","volume":"17","author":"Fenta","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.clinthera.2024.01.010_bib0012","unstructured":"MoriskyScales. MMAS-4, MMAS-8. Morisky Medical Adherence Research. Accessed February 13, 2024. https:\/\/www.moriskyscale.com\/mmas-4\u2013mmas-8-the-morisky-scales.html#\/"},{"key":"10.1016\/j.clinthera.2024.01.010_bib0013","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4070\/kcj.2012.42.2.113","article-title":"Trends in oral anticoagulation therapy among Korean patients with atrial fibrillation: the Korean Atrial Fibrillation Investigation","volume":"42","author":"Shin","year":"2012","journal-title":"Korean Circ J"},{"issue":"1","key":"10.1016\/j.clinthera.2024.01.010_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227458","article-title":"A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa","volume":"15","author":"Semakula","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clinthera.2024.01.010_bib0015","doi-asserted-by":"crossref","first-page":"e44S","DOI":"10.1378\/chest.11-2292","article-title":"Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Ageno","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2024.01.010_bib0016","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.clinthera.2012.06.002","article-title":"Identifying potential predictors of high-quality oral anticoagulation assessed by time in therapeutic international normalized ratio range: a prospective, long-term, single-center, observational study","volume":"34","author":"de Barros Costa","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2024.01.010_bib0017","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2147\/JBM.S282948","article-title":"Evaluation of warfarin anticoagulation at university of Gondar comprehensive specialized hospital, north-west Ethiopia","author":"Masresha","year":"2021","journal-title":"J Blood Med"},{"key":"10.1016\/j.clinthera.2024.01.010_bib0018","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/CIRCOUTCOMES.109.862763","article-title":"Epidemiology of subtherapeutic anticoagulation in the United States","volume":"2","author":"Rose","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824000183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824000183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T12:56:10Z","timestamp":1716296170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291824000183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0149291824000183"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.01.010","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attainment of Target in Therapeutic Range of International Normalized Ratio and Correlates Among Patients on Warfarin Therapy at Jimma Medical Center, Jimma, Ethiopia","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}